Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 9
Submit an article Journal homepage
310
Views
5
CrossRef citations to date
0
Altmetric
Letters to the Editor

Progressive multifocal leukoencephalopathy during treatment with lenalidomide and elotuzumab for multiple myeloma

Yuta UsuiDepartment of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan; View further author information
,
Hiroto NakanoDepartment of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan; View further author information
,
Junji KomatsuDepartment of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan; View further author information
,
Kazuo NakamichiDepartment of Virology 1, National Institute of Infectious Diseases, Tokyo, Japan; View further author information
,
Masayuki SaijoDepartment of Virology 1, National Institute of Infectious Diseases, Tokyo, Japan; View further author information
,
Seiichiro TakanoDepartment of Neurology, Fukui Red Cross Hospital, Fukui, Japan; View further author information
,
Ken-ichi KamiyaDepartment of Hematology, Fukui Red Cross Hospital, Fukui, JapanView further author information
,
Tsuyoshi HamaguchiDepartment of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan; View further author information
&
Masahito YamadaDepartment of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan; Correspondence[email protected]
View further author information
 show all
Pages 2234-2237 | Received 11 Mar 2020, Accepted 27 Apr 2020, Published online: 18 May 2020
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Ethics approval

This is not a clinical trial, but a case report. Although the patient was treated with mefloquine and mirtazapine, which are not approved as medications for PML by pharmaceutical and medical device agencies in Japan, the institutional committee for the evaluation of highly difficult new medical technologies approved the treatment.

Author contributions

YU, HN, JK, ST, KK, TH, and MY performed the clinical and bedside studies. KN, MS and ST performed the PCR for the detection of JCV. YU wrote the initial draft of the paper and all authors contributed to its preparation. The final version was read and approved by all authors.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

This work was supported by JSPS KAKENHI [Grant Number 17H04194] (to KN).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.